Zepp Health logo

ZEPP - Zepp Health Share Price

$9.57 0.0  0.2%

Last Trade - 9:00pm

Mid Cap
Market Cap £430.1m
Enterprise Value £237.0m
Revenue £717.3m
Position in Universe 3362nd / 6854
Unlock ZEPP Revenue
Relative Strength (%)
1m -16.0%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -52.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
896.5 1,556 2,049 3,645 5,812 6,433 7,464 8,734 +48.3%
+152 +321.1 -69.4 +171.5 +53.4
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, ZeppHealth Corp - ADR revenues increased 11% to RMB6.43B. Netincome applicable to common stockholders decreased 60% toRMB228.8M. Revenues reflect Self-branded Products & Otherssegment increase of 23% to RMB2B, Xiaomi Wearable Productssegment increase of 6% to RMB4.44B. Net income was offsetby Research and development - Balancing val increase of 22%to RMB514M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ZEPP Revenue Unlock ZEPP Revenue

Net Income

ZEPP Net Income Unlock ZEPP Revenue

Normalised EPS

ZEPP Normalised EPS Unlock ZEPP Revenue

PE Ratio Range

ZEPP PE Ratio Range Unlock ZEPP Revenue

Dividend Yield Range

ZEPP Dividend Yield Range Unlock ZEPP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ZEPP EPS Forecasts Unlock ZEPP Revenue
Profile Summary

Zepp Health Corp, formerly Huami Corp, is a company committed to connect health with technology. It has developed a platform of proprietary technology including artificial intelligence (AI) chips, biometric sensors, and health data algorithms. It is engaged in developing smart wearable technology. It designs and develops biometric and activity data-driven fitness and smart watches. It markets its products under the brand name, Amazfit and is the sole partner for Xiaomi wearable products. The products includes Amazfit BIP, Amazfit pace, Amazfit equator, Amazfit ARC, and accessories, such as sports bands, watch straps, ear buds, charging units, and core trackers. The smart watches provides activity tracking, sleep tracking, smart notifications from mobile devices, GPS, heart rate sensing, water resistance, wireless syncing with mobile phones. It also provides a mobile application to keep track of the fitness information, set alarms and receive call notifications on the smart watch.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since February 8, 2018
No. of Shareholders: n/a
No. of Employees: 1,507
Sector Technology
Industry Computers, Phones & Household Electronics
Exchange New York Stock Exchange
Shares in Issue 62,536,291
Free Float (0.0%)
Eligible for
ZEPP Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ZEPP
Upcoming Events for ZEPP
Thursday 13th May, 2021
Q1 2021 Zepp Health Corp Earnings Call
Thursday 13th May, 2021
Q1 2021 Zepp Health Corp Earnings Release
Frequently Asked Questions for Zepp Health
What is the Zepp Health share price?

As of 9:00pm, shares in Zepp Health are trading at $9.57, giving the company a market capitalisation of £430.1m. This share price information is delayed by 15 minutes.

How has the Zepp Health share price performed this year?

Shares in Zepp Health are currently trading at $9.57 and the price has moved by -26.54% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zepp Health price has moved by -49.21% over the past year.

What are the analyst and broker recommendations for Zepp Health?

Of the analysts with advisory recommendations for Zepp Health, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Zepp Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Zepp Health next release its financial results?

Zepp Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Zepp Health dividend yield?

Zepp Health does not currently pay a dividend.

Does Zepp Health pay a dividend?

Zepp Health does not currently pay a dividend.

When does Zepp Health next pay dividends?

Zepp Health does not currently pay a dividend.

How do I buy Zepp Health shares?

To buy shares in Zepp Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zepp Health?

Shares in Zepp Health are currently trading at $9.57, giving the company a market capitalisation of £430.1m.

Where are Zepp Health shares listed? Where are Zepp Health shares listed?

Here are the trading details for Zepp Health:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: ZEPP
What kind of share is Zepp Health?

Based on an overall assessment of its quality, value and momentum, Zepp Health is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zepp Health share price forecast 2021?

Shares in Zepp Health are currently priced at $9.57. At that level they are trading at 0.49% discount to the analyst consensus target price of 0.00.

Analysts covering Zepp Health currently have a consensus Earnings Per Share (EPS) forecast of 7.462 for the next financial year.

How can I tell whether the Zepp Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zepp Health. Over the past six months, the relative strength of its shares against the market has been -36.24%. At the current price of $9.57, shares in Zepp Health are trading at -26.61% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zepp Health PE Ratio?

The Zepp Health PE ratio based on its reported earnings over the past 12 months is 22.45. The shares are currently trading at $9.57.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Zepp Health?

Zepp Health's management team is headed by:

Wang Huang - CHM
De Liu - DRC
Yunfen Lu - DRC
Xiaojun Zhang - DRC
Jimmy Lai - IND
Mike Yeung - COO
Hui Wang - VPR
Pengtao Yu - OTH
Leon Cheng Deng - CFO
Bing Xie - IND
Who are the major shareholders of Zepp Health?

Here are the top five shareholders of Zepp Health based on the size of their shareholding:

Wells Capital Management Inc. Investment Advisor/Hedge Fund
Percentage owned: 17.21% (5.79m shares)
Shunwei Capital Partners Venture Capital
Percentage owned: 12.33% (4.15m shares)
Banyan Partners Fund I LP Corporation
Percentage owned: 7.67% (2.58m shares)
Wells Fargo Advantage Emerging Markets Equity Fund Mutual Fund
Percentage owned: 6.3% (2.12m shares)
Goldman Sachs Asset Management, L.P. Investment Advisor
Percentage owned: 4.59% (1.55m shares)
Similar to ZEPP
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.